Skip to main content
Fig. 6 | Cardiovascular Diabetology

Fig. 6

From: Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Fig. 6

Relative expression (2−ΔCq, ΔCq = Cq has-miRNA—Cq U6) of miRNAs in MVs from the plasma of patients with dyslipidemia (n = 14), diabetes (n = 17), diabetes associated with dyslipidemia (n = 17) and of healthy subjects taken as control (n = 15): A miR-21-5p; B miR-122-5p; C miR 126-3p; D miR-155-5p; E miR-223-3p. Data are expressed as means ± SD. &p < 0.05, &&p < 0.01, &&&p < 0.001 (vs C), #p < 0.05 (vs T2D) (One-Way ANOVA with Bonferroni's Multiple Comparison Test)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840